Literature DB >> 15201801

Long-term outcome of vesicoureteral reflux associated chronic renal failure in children. Data from the ItalKid Project.

Gianluigi Ardissino1, Luigi Avolio, Valeria Dacco, Sara Testa, Giuseppina Marra, Sara Viganò, Silvana Loi, Paolo Caione, Roberto De Castro, Salvatore De Pascale, Efisia Marras, Giovanna Riccipetitoni, Giorgio Selvaggio, Paola Pedotti, Aldo Claris-Appiani, Antonio Ciofani, Luca Dello Strologo, Giuliana Lama, Giovanni Montini, Enrico Verrina.   

Abstract

PURPOSE: The nephropathy associated with vesicoureteral reflux (VUR) is one of the leading causes of chronic renal failure (CRF) in children. We describe the clinical course of the disease based on information available in the ItalKid Project database, and analyze the predictive value of baseline renal function, age at VUR diagnosis and urinary protein excretion in relation to the risk of progressive renal failure.
MATERIALS AND METHODS: As of December 31, 2001 the registry included a total of 343 patients (261 males) with a diagnosis of primary VUR, which was the leading single cause of CRF, accounting for 25.4% of all patients with CRF.
RESULTS: The estimated risk of end stage renal disease (ESRD) by age 20 years was 56%. The patients with a creatinine clearance (Ccr) of less than 40 ml per minute at baseline had an estimated 4-fold greater risk of ESRD developing in comparison with those whose Ccr was 40 to 75 ml per minute. No significant difference in probability of disease progression to ESRD was found between subjects diagnosed with VUR at age 6 months or less and those diagnosed later (older than 6 months). Furthermore, children with normal urinary protein excretion (a urinary protein [uPr]/urinary creatinine [uCr] ratio of less than 0.2 in 36 patients) and low grade proteinuria (uPr/uCr 0.2 to 0.8 in 34 patients) at baseline showed a significantly slower decrease in mean Ccr than those with moderate proteinuria (uPr/uCr greater than 0.8 in 34 patients). Hypertension and/or antihypertensive treatment (including antiprogressive drugs) were reported in 29.1% of patients.
CONCLUSIONS: The results of the present study define the long-term risk of ESRD in a large population of children with CRF and VUR, and provide some critical information for identifying the prognosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15201801     DOI: 10.1097/01.ju.0000129067.30725.16

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  17 in total

1.  Profiling proteinuria in pediatric patients.

Authors:  Carolyn L Abitbol; Jayanthi Chandar; Ali Mirza Onder; Obioma Nwobi; Brenda Montané; Gastón Zilleruelo
Journal:  Pediatr Nephrol       Date:  2006-05-20       Impact factor: 3.714

Review 2.  Relevance of current guidelines in the management of VUR.

Authors:  Alexander Springer; Ramnath Subramaniam
Journal:  Eur J Pediatr       Date:  2014-01-03       Impact factor: 3.183

3.  [Primary vesicoureteral reflux].

Authors:  R Stein; C Ziesel; P Rubenwolf; R Beetz
Journal:  Urologe A       Date:  2013-01       Impact factor: 0.639

4.  Urological disorders in chronic kidney disease in children cohort: clinical characteristics and estimation of glomerular filtration rate.

Authors:  Jennifer L Dodson; Judith V Jerry-Fluker; Derek K Ng; Marva Moxey-Mims; George J Schwartz; Vikas R Dharnidharka; Bradley A Warady; Susan L Furth
Journal:  J Urol       Date:  2011-10       Impact factor: 7.450

5.  Vesico-ureteric reflux: using mouse models to understand a common congenital urinary tract defect.

Authors:  Inga J Murawski; Christine L Watt; Indra R Gupta
Journal:  Pediatr Nephrol       Date:  2011-03-20       Impact factor: 3.714

6.  Urodynamics investigation on children with vesicoureteral reflux identifies overactive bladder and poor compliance in those with voiding dysfunction.

Authors:  Emanuela Altobelli; Maurizio Buscarini; Simona Gerocarni Nappo; Hiep T Nguyen; Paolo Caione
Journal:  Pediatr Surg Int       Date:  2011-05       Impact factor: 1.827

7.  Reliability of grading of vesicoureteral reflux and other findings on voiding cystourethrography.

Authors:  Anthony J Schaeffer; Saul P Greenfield; Anastasia Ivanova; Gang Cui; J Michael Zerin; Jeanne S Chow; Alejandro Hoberman; Ranjiv I Mathews; Tej K Mattoo; Myra A Carpenter; Marva Moxey-Mims; Russell W Chesney; Caleb P Nelson
Journal:  J Pediatr Urol       Date:  2016-09-06       Impact factor: 1.830

8.  The KIDSTEM European Research Training Network: Developing a Stem Cell Based Therapy to Replace Nephrons Lost through Reflux Nephropathy.

Authors:  Patricia Murray; Giovanni Camussi; Jamie A Davies; David Edgar; Markus Hengstschlager; Simon Kenny; Giuseppe Remuzzi; Carsten Werner
Journal:  Organogenesis       Date:  2007-01       Impact factor: 2.500

9.  Vesicoureteric reflux is not a benign condition.

Authors:  Malcolm G Coulthard
Journal:  Pediatr Nephrol       Date:  2008-06-27       Impact factor: 3.714

10.  Urinary incontinence in the CKiD cohort and health related quality of life.

Authors:  Jennifer L Dodson; Silvia E Cohn; Christopher Cox; Paul S Hmiel; Ellen Wood; Tej K Mattoo; Bradley A Warady; Susan L Furth
Journal:  J Urol       Date:  2009-08-20       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.